These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 7865177)
1. Effects of D-cycloserine and (+)-HA-966 on the locomotor stimulation induced by NMDA antagonists and clonidine in monoamine-depleted mice. Carlsson ML; Engberg G; Carlsson A J Neural Transm Gen Sect; 1994; 95(3):223-33. PubMed ID: 7865177 [TBL] [Abstract][Full Text] [Related]
2. The non-competitive NMDA antagonists MK-801 and PCP, as well as the competitive NMDA antagonist SDZ EAA494 (D-CPPene), interact synergistically with clonidine to promote locomotion in monoamine-depleted mice. Carlsson M; Svensson A Life Sci; 1990; 47(19):1729-36. PubMed ID: 2147454 [TBL] [Abstract][Full Text] [Related]
3. Anticonvulsant effects of the glycine/NMDA receptor ligands D-cycloserine and D-serine but not R-(+)-HA-966 in amygdala-kindled rats. Löscher W; Wlaź P; Rundfeldt C; Baran H; Hönack D Br J Pharmacol; 1994 May; 112(1):97-106. PubMed ID: 8032669 [TBL] [Abstract][Full Text] [Related]
4. Ethanol behaves as an NMDA antagonist with respect to locomotor stimulation in monoamine-depleted mice. Carlsson ML; Engberg G J Neural Transm Gen Sect; 1992; 87(2):155-60. PubMed ID: 1558743 [TBL] [Abstract][Full Text] [Related]
5. Low doses of the glycine/NMDA receptor antagonist R-(+)-HA-966 but not D-cycloserine induce paroxysmal activity in limbic brain regions of kindled rats. Wlaź P; Ebert U; Löscher W Eur J Neurosci; 1994 Nov; 6(11):1710-9. PubMed ID: 7874310 [TBL] [Abstract][Full Text] [Related]
6. Effect of the glycine/NMDA receptor partial agonist, D-cycloserine, on seizure threshold and some pharmacodynamic effects of MK-801 in mice. Wlaź P; Baran H; Löscher W Eur J Pharmacol; 1994 May; 257(3):217-25. PubMed ID: 8088343 [TBL] [Abstract][Full Text] [Related]
7. Competitive antagonists and partial agonists at the glycine modulatory site of the mouse N-methyl-D-aspartate receptor. Henderson G; Johnson JW; Ascher P J Physiol; 1990 Nov; 430():189-212. PubMed ID: 1707965 [TBL] [Abstract][Full Text] [Related]
8. Crucial role of the accumbens nucleus in the neurotransmitter interactions regulating motor control in mice. Svensson A; Carlsson ML; Carlsson A J Neural Transm Gen Sect; 1995; 101(1-3):127-48. PubMed ID: 8695043 [TBL] [Abstract][Full Text] [Related]
9. Differential locomotor interactions between dopamine D1/D2 receptor agonists and the NMDA antagonist dizocilpine in monoamine-depleted mice. Svensson A; Carlsson A; Carlsson ML J Neural Transm Gen Sect; 1992; 90(3):199-217. PubMed ID: 1363051 [TBL] [Abstract][Full Text] [Related]
10. Dramatic synergism between MK-801 and clonidine with respect to locomotor stimulatory effect in monoamine-depleted mice. Carlsson M; Carlsson A J Neural Transm; 1989; 77(1):65-71. PubMed ID: 2545813 [TBL] [Abstract][Full Text] [Related]
11. Central effects of SL 82.0715, an antagonist of polyamine site of the NMDA receptor complex. Dereń-Wesołek A; Maj J Pol J Pharmacol; 1993; 45(5-6):467-80. PubMed ID: 7912135 [TBL] [Abstract][Full Text] [Related]
12. Interfering with glutamatergic neurotransmission by means of NMDA antagonist administration discloses the locomotor stimulatory potential of other transmitter systems. Carlsson M; Svensson A Pharmacol Biochem Behav; 1990 May; 36(1):45-50. PubMed ID: 2161545 [TBL] [Abstract][Full Text] [Related]
13. Intrathecally administered D-cycloserine produces nociceptive behavior through the activation of N-methyl-D-aspartate receptor ion-channel complex acting on the glycine recognition site. Tan-No K; Esashi A; Nakagawasai O; Niijima F; Furuta S; Sato T; Satoh S; Yasuhara H; Tadano T J Pharmacol Sci; 2007 May; 104(1):39-45. PubMed ID: 17452810 [TBL] [Abstract][Full Text] [Related]
14. Injection of the competitive NMDA receptor antagonist AP-5 into the nucleus accumbens of monoamine-depleted mice induces pronounced locomotor stimulation. Svensson A; Carlsson ML Neuropharmacology; 1992 May; 31(5):513-8. PubMed ID: 1356250 [TBL] [Abstract][Full Text] [Related]
15. Chemically-diverse ligands at the glycine B site coupled to N-methyl-D-aspartate (NMDA) receptors selectively block the late phase of formalin-induced pain in mice. Millan MJ; Seguin L Neurosci Lett; 1994 Aug; 178(1):139-43. PubMed ID: 7816323 [TBL] [Abstract][Full Text] [Related]
16. Discriminative stimulus effects of R-(+)-3-amino-1-hydroxypyrrolid-2-one, [(+)-HA-966], a partial agonist of the strychnine-insensitive modulatory site of the N-methyl-D-aspartate receptor. Witkin JM; Brave S; French D; Geter-Douglass B J Pharmacol Exp Ther; 1995 Dec; 275(3):1267-73. PubMed ID: 8531091 [TBL] [Abstract][Full Text] [Related]
17. In vivo modulation of the N-methyl-D-aspartate receptor complex by D-serine: potentiation of ongoing neuronal activity as evidenced by increased cerebellar cyclic GMP. Wood PL; Emmett MR; Rao TS; Mick S; Cler J; Iyengar S J Neurochem; 1989 Sep; 53(3):979-81. PubMed ID: 2547911 [TBL] [Abstract][Full Text] [Related]
18. Synergistic interactions between muscarinic antagonists, adrenergic agonists and NMDA antagonists with respect to locomotor stimulatory effects in monoamine-depleted mice. Carlsson M; Svensson A; Carlsson A Naunyn Schmiedebergs Arch Pharmacol; 1991 Jun; 343(6):568-73. PubMed ID: 1682816 [TBL] [Abstract][Full Text] [Related]
20. The contribution of the different binding sites of the N-methyl-D-aspartate (NMDA) receptor to the expression of behavior. Kretschmer BD; Zadow B; Volz TL; Volz L; Schmidt WJ J Neural Transm Gen Sect; 1992; 87(1):23-35. PubMed ID: 1346965 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]